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Abstract Naked mole-rats (NMRs) have amongst the
longest lifespans relative to body size of any known,
non-volant mammalian species. They also display an
enhanced stress resistance phenotype, negligible senes-
cence and very rarely are they burdened with chronic
age-related diseases. Alternative splicing (AS) dysregu-
lation is emerging as a potential driver of senescence
and ageing. We hypothesised that the expression of
splicing factors, important regulators of patterns of AS,
may differ in NMRs when compared to other species
with relatively shorter lifespans. We designed assays
specific to NMR splicing regulatory factors and also to
a panel of pre-selected brain-expressed genes known to
demonstrate senescence-related alterations in AS in oth-
er species, and measured age-related changes in the
transcript expression levels of these using embryonic
and neonatal developmental stages through to extreme
old age in NMR brain samples. We also compared
splicing factor expression in both young mouse and
NMR spleen and brain samples. Both NMR tissues
showed approximately double the expression levels ob-
served in tissues from similarly sized mice. Further-
more, contrary to observations in other species, follow-
ing a brief period of labile expression in early life stages,
adult NMR splicing factors and patterns of AS for
functionally relevant brain genes remained remarkably
stable for at least two decades. These findings are con-
sistent with a model whereby the conservation of splic-
ing regulation and stable patterns of AS may contribute
to better molecular stress responses and the avoidance of
senescence in NMRs, contributing to their exceptional
lifespan and prolonged healthspan.
Keywords Nakedmole-rat .Heterocephalus glaber .
Ageing . Splicing factors . hnRNPs . Srsfs . Klotho .
CDKN2A . Cognitive function . DNA repair
Introduction
Naked mole-rats (NMRs; Heterocephalus glaber) are
eusocial animals which live in subterranean colonies of
up to 300 individuals with a single breeding female, in a
manner analogous to bees or other social insects (Jarvis
1981; Brett 1991). Similarly sized rodents such as mice
have a lifespan limited to 3–4 years, whereas NMRs
typically survive to over 20 years of age, with a maxi-
mum recorded lifespan of 37 years in a still extant male.
This is approximately 5-fold greater than that predicted
from their small body size (Edrey et al. 2011). This
extraordinary lifespan is accompanied by extended
“healthspan”, with virtually no increase in Gompertzian
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mortality risk with age (Buffenstein et al. 2012; Ruby
et al. 2018). Both fertility and neurogenesis persist for
decades (Holmes 2016; Lewis and Buffenstein 2016a,
b). NMRs are resistant to both spontaneous and exper-
imentally induced cancer (Liang et al. 2010; Delaney
et al. 2013; Deweerdt 2014). Moreover, NMRs demon-
strate few age-related metabolic, cardiac or vascular
changes (O'Connor et al. 2002; Csiszar et al. 2007;
Buffenstein 2008; Grimes et al. 2014; Triplett et al.
2015a, b; Delaney et al. 2016). Indeed, considerable
evidence suggests they maintain an overall youthful
phenotype throughout their long lives (Buffenstein
et al. 2019), for example they retain foetal haemoglobin
throughout their lives, facilitating more efficient oxygen
transport and clearly an evolved adaption to the hypoxic
challenges of their colonial, subterranean habitation.
Having resided in this harsh milieu since the early
Miocene, they have evolved numerous adaptations to
deal with the many conditions imposed by their subter-
ranean habitation (e.g. hypercapnia, hypoxia, exposure
to heavy metals, and plant secondary defence mecha-
nisms) for review see (Lewis and Buffenstein 2016a, b).
For example, NMRs can survive 18min in pure nitrogen
atmospheres and under these anoxic conditions switch
from glucose-based anaerobic metabolism to that of
fructose and appear to have several neuroprotective
mechanisms to prevent neuronal death under hypoxia
(Park et al. 2017; Munro et al. 2019). These long living,
resilient animals therefore present an interesting paradox
in ageing biology and an opportunity to examine funda-
mental mechanisms of ageing.
Several molecular explanations for the enhanced lon-
gevity and negligible levels of senescence (Buffenstein
2008) of NMRs have been proposed, most of which align
to the established “hallmarks of ageing” (Lopez-Otin
et al. 2013; Dammann 2017). NMRs have a low meta-
bolic rate approximately 70% of that of a laboratory
mouse (Yahav and Buffenstein 1991), enhanced expres-
sion of DNA repair genes (MacRae et al. 2015), resis-
tance to oxidative stress (Lewis et al. 2013), well-
maintained proteostasis (Perez et al. 2008; Pride et al.
2015), enhanced autophagy (Zhao et al. 2014), improved
telomere maintenance (Evfratov et al. 2014), a stable
epigenome (Tan et al. 2017), a well-maintained circulat-
ing and hepatic metabolome consistent with methionine
and dietary restriction (Heinze et al. 2018; Lewis et al.
2018; Viltard et al. 2019) and concomitant high levels of
cystathionine β-synthase (CBS) activation (Olecka et al.
2018), a novel immune system (Hilton et al. 2019), and
show few signs of cellular senescence both in vitro (Zhao
et al. 2018) and in vivo (Buffenstein 2008). The lack of
senescence is of particular interest since targeted ablation
of p16INK-4a positive senescent cells in genetically altered
mouse models is able to extend lifespan and bring about
improvements in many of the features of old age (Baker
et al. 2011; Baker et al. 2016; Baar et al. 2017; Baar et al.
2018; Baker and Petersen 2018). Senescent cells are
thought to drive ageing phenotypes by a number of
mechanisms, not least the secretion of the senescence-
associated secretory phenotype (SASP) and transcription-
al changes brought about through chromatin remodelling
(van Deursen 2014). Senotherapeutic interventions in
man are in their infancy, but have been reported to have
some beneficial effects in patients with idiopathic pulmo-
nary fibrosis or chronic kidney disease (Hickson et al.
2019; Justice et al. 2019).
Cellular senescence can arise because of failure in
molecular stress response as may occur during oncogen-
ic insults (de Magalhaes and Passos 2018) and during
development. A key component of this is the ability to
maintain an active and plastic transcriptome. In response
to internal and external stimuli, cells must be able to
effectively reprogram their gene expression
(Guzikowski et al. 2019). Alternative splicing (AS),
one mechanism by which genes can produce a variety
of functionally different isoforms from a single coding
unit, is a key component of transcriptomic plasticity, and
is especially responsive to stress (Nevo et al. 2012; Pai
and Luca 2019). Unlike constitutive splicing, which
occurs for all multi-exon genes, AS brings about the
expression of a repertoire of multiple isoforms, which
may be temporally or spatially regulated, or differ in
response to stimuli. Alternative isoforms commonly
have variant or antagonistic functions (Stamm et al.
2005; Villate et al. 2008). AS events may comprise
alternative (cassette exons) exons, alternative 5′ or 3′
splice site usage, intron inclusion or deletions of parts of
exons.More than one of these phenomenamay be active
in any given gene (Pai and Luca 2019). AS decisions are
made by the binding of serine-arginine rich (SR) splic-
ing activator proteins (SRSFs) and heterogeneous nu-
clear ribonucleoprotein particle (hnRNP) splicing inhib-
itor proteins to exon and intron splicing enhancer or
silencer sequences around the splice sites (Cartegni
et al. 2002). Each splice site is regulated by the combi-
national and competitive binding of a unique combina-
tion of activators and inhibitors (Smith and Valcarcel
2000). These activator and inhibitor proteins are
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collectively termed splicing factors. AS has previously
been reported in NMRs, as in other higher organisms,
including for important senescence-associated loci such
as CDKN2A (Tian et al. 2015).
Correct regulation of AS is critical to ageing; genes
encoding components of the splicing regulatorymachin-
ery are amongst the most dysregulated by age in human
populations and in senescent human fibroblasts, endo-
thelial cells, cardiomyocytes and astrocytes. Splicing
factor expression is mainly downregulated in senescent
cells of these subtypes, but tissue-specific differences in
both the identity of affected splicing factors and direc-
tionality do exist (Harries et al. 2011; Holly et al. 2013;
Latorre et al. 2017; Latorre et al. 2018a; Latorre et al.
2018b; Lye et al. 2019). The expression of splicing
regulatory factor genes are also associated with lifespan
and dietary restriction in mice and other species (Heintz
et al. 2016; Lee et al. 2016; Lee et al. 2019a), and
predictively linked with human ageing phenotypes in
population studies (Lee et al. 2019b; Lye et al. 2019).
Splicing factors expression is tightly connected to con-
trol of cell proliferation with splicing factors frequently
mutated in cancer (Seiler et al. 2018). Finally, restora-
tion of splicing factor expression using small molecules
or targeted genetic interventions is able to reverse mul-
tiple features of senescence in aged human primary cells
in vitro (Latorre et al. 2017; Latorre et al. 2018a, c).
We hypothesised that given the lack of visible signs
of senescence in ageing NMRs and the importance of
splicing factor regulation in the context of senescence,
that splicing factor dysregulation and the consequent
changes to the splicing patterns in ageing cells and
tissues (Harries et al. 2011; Latorre et al. 2018b; Lye
et al. 2019) may not be a feature of NMR ageing. We
aimed to characterise the abundance of an a priori panel
of 20 splicing factors known to be important in ageing
and senescence from our previous work (Holly et al.
2013; Latorre et al. 2017; Latorre et al. 2018a, b, c), in a
series of whole brain samples originating from embry-
onic NMRs all the way up to extreme old age. Brain
expression levels of a panel of senescence-related genes,
and AS patterns of a candidate series of functionally
relevant brain isoforms previously identified to be al-
tered in replicatively senescent human astrocytes (Lye
et al. 2019) were also assessed as a functional output of
splicing factor expression. We determined that although
changes are evident in the brain expression of splicing
factor genes between embryonic and adult states as
expected, splicing factor expression trajectories remain
static over the course of NMR ageing, as do the expres-
sion patterns of important alternatively spliced brain
function genes. Furthermore we identified no increase
in the expression of important molecular markers of
cellular senescence (including isoforms of the Cdkn1a
Tp53 and Cdkn2a genes), in accordance with the negli-
gible senescence phenotype in these animals. Our data
are supportive of a hypothesis that the extraordinary
longevity of NMRs may arise at least in part from
maintained transcriptomic molecular stress responses,
conservation of regulated alternative splicing leading
to avoidance of cellular senescence, a post-
transcription mechanism of gene expression regulation.
Methods
Animal characteristics and husbandry
The NMRs used in this study were part of the well
characterised Calico colony. The progenitors of these
animals were collected in Kenya. All animals are
microchipped at 90 days of age, providing each individ-
ual with a unique nine-digit identifying number. NMRs
were housed in multi-chambered plexiglass burrow sys-
tems in animal rooms maintained at 28–30 °C and 30–
50% relative humidity, in attempts to simulate climatic
conditions in their native equatorial habitat. The animals
were fed ad libitum with fruit and vegetables (bananas,
apples, oranges, butternut squash, red bell pepper, ro-
maine lettuce, cucumber, green beans, corn, carrots and
red garnet yams) and supplemented with a high protein
and vitamin enriched cereal (Pronutro, South Africa).
Animals, ranging from neonates to 22 years old, as
well as pregnant females were euthanised using
isoflurane and killed by cardiac exsanguination. Four
to eight animals of both sexes were used in each age
cohort (Table 1). Tissues were harvested from the em-
bryos and animals of different ages and immediately
flash frozen in liquid nitrogen and stored at -80 °C until
analysed. Brain and spleen samples were used in these
studies. We chose spleen because, as a lymphoid organ,
it consists of large numbers of white blood cells. Most of
the transcripts extracted from spleen will arise from B
cells, T cells and mononuclear phagocytes and may
allow a window on “inflammaging”, thought to be a
prominent ageing mechanism (Zuo et al. 2019). Brain
was chosen as splicing patterns are especially complex
and functionally important in this organ (Karlsson and
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Linnarsson 2017), and dysregulated splicing is a feature
of many neurodegenerative and neurodevelopmental
diseases in brain (Nik and Bowman 2019). All animal
use and experiments were approved by the Buck Insti-
tute Institutional Animal Care and Use Committee
(IACUC) protocol number A10173.
Candidate genes selected for analysis
An a priori list of splicing factor candidate genes were
chosen based on associations with ageing or senescence
in multiple human ageing cohorts and in senescent
primary human cell lines (Harries et al. 2011; Holly
et al. 2013; Latorre et al. 2017; Latorre et al. 2018b).
Some of the splicing factors in this list have also been
shown to associate with lifespan in both mice and
humans (Lee et al. 2016) and cognitive dysfunction in
human populations (Lee et al. 2019b), or to be involved
in molecular responses to dietary restriction (Lee et al.
2019a). The list of genes included the negative regula-
tory splicing factors Hnrnpa0, Hnrnpa1, Hnrnpa2b1,
Hnrnpd, Hnrnph3, Hnrnpk, Hnrnpm, Hnrnpul2, the
positive regulatory splicing enhancers Pnisr, Srsf1,
Srsf2, Srsf3, Srsf6, Tra2b and the core components of
the spliceosome Sf1 and Sf3b1. A further panel of alter-
natively spliced candidate genes where specific iso-
forms have known links to brain function/dysfunction
(Lye et al. 2019) and/or have been demonstrated to be
dysregulated in senescent astrocytes (Lye et al. 2019) or
linked with cognitive dysfunction in human populations
(Lye et al. 2019), and/or neurodegenerative disease were
chosen for analysis. These were Aph1a, App, Aqp4,
Gfap, Klotho, Mapt, Psen1 and Psen2. An additional
panel of transcripts known to be associated with senes-
cence were also used: Atm, Cdkn1a, Cdkn2a, Cdkn2b
and Tp53. Table 2 lists all genes/isoforms tested in this
panel, rationale for their inclusion and references to
supporting literature. Isoform structures are given in
Supplementary figure S1. Six endogenous control genes
were also selected on the basis of stability in ageing
human populations (Harries et al. 2011): Hprt1, Idh3b,
Polr2a, Ppia, Tbp and Ywhaz, however assays to Hprt1
and Ywhaz were subsequently excluded due to poor
assay performance.
RNA extraction
Snap-frozen tissues were first treated with RNAlater™-
ICE Frozen Tissue Transition Solution (ThermoFisher,
Waltham, MA, USA) according to the manufacturer’s
instructions, to allow handling of tissue without RNA
degradation occurring due to thawing of sample. Tissue
sections were placed in 1 mL TRI Reagent® Solution
(ThermoFisher, Waltham, MA, USA) supplemented
with the addition of 10 mM MgCl2 to aid recovery of
microRNAs (Kim et al. 2012). Samples were complete-
ly homogenised in a bead mill (Retsch Technology
GmbH, Haan, Germany) at a frequency of 30 cycles
per second for 15 min. Phase separation was carried out
using chloroform. Total RNAwas precipitated from the
aqueous phase bymeans of an overnight incubation at −
20 °C with isopropanol. A total of 1.2 μl Invitrogen™
GlycoBlue™ Coprecipitant (ThermoFisher, Waltham,
MA, USA) was added prior to incubation to aid pellet
recovery. RNA pellets were ethanol-washed twice and
re-suspended in 1× TE buffer, pH 8.0. RNA quality and
concentration were assessed by NanoDrop spectropho-
tometry (NanoDrop, Wilmington, DE, USA).
Reverse transcription
For RTPCR and Sanger sequencing as described below,
a pool of 1000 ng of total RNA taken from 10 samples
(one sample chosen at random from each NMR age
group) was reverse transcribed using EvoScript Univer-
sal cDNA Master kit (Roche LifeScience, Burgess Hill,
West Sussex, UK) in single 20μl reactions, according to
the manufacturer’s instructions, with the exception of a
change to the extension phase of the reaction: a step of
30 min at 65 °C was used instead of 15 min at 65 °C.
Resulting cDNA samples were diluted to a final volume
Table 1 Details of animals used in the study. Shown here are the
numbers and age ranges of naked mole rats included in each age
category in the current study
Sample subset Age range (days) n
Foetus – 5
1 day 1 6
2 weeks 14 4
3–4 years 1095–1793 8
5–6 years 2163–2478 4
7–8 Years 2631–2920 4
9–12 years 3306–4264 6
13–15 years 4745–5326 5
17–20 years 6264–7300 5


































































































































































































































































































































































































































































































































































































































































































































































































































































































































of 75 μl with dH2O, and repeated as necessary to pro-
vide sufficient template for all RTPCR and sequencing
reactions carried out. For assay validation by standard
curve, reactions as described above were carried out in
quadruplicate and pooled prior to a 6-step 1:2 dilution
series. For qPCR, 1500 ng of total RNA was reverse
transcribed using SuperScript®VILO™ cDNA Synthe-
sis Kit (ThermoFisher, Waltham, MA, USA) in 20 μl
reactions, according to the manufacturer’s instructions
(Thermofisher n.d.a, b). Resulting cDNA samples were
diluted to a final volume of 150 μl with dH2O to ensure
sufficient volume for all subsequent qPCR reactions.
Assay design
Quantitative real-time reverse transcriptase PCR
(qPCR) assays to mouse splicing factor assays were
obtained from Thermo Fisher (ThermoFisher, Waltham,
MA, USA). Assay Ids are available on request. Assays
to NMR splicing factors and alternatively expressed
isoforms were custom designed to determine expression
levels of all candidate mRNAs. Given that the current
NMR genome is not completely annotated, this required
a four-step design process, as follows:
(a) “In silico” sequence alignment: Where genes were
not being tested for alternate isoform expression,
the genome sequences of genes in question were
obtained from the UCSC Genome Browser (Kent
et al. 2002) for the following species: NMR, Guin-
ea pig, Rat, Mouse and Human (see Supplementary
Table S1 for assemblies used). Intronic sequences
were removed and resulting “in silico-spliced” se-
quences manually aligned across all 5 species to
identify areas of highest homology. Where feasi-
ble, exon boundaries within the regions of high
homology were then selected as target areas for
design of qPCR assays. Where alternate isoforms
exist and were required to be assessed, evidence
from previous literature was sought to identify the
isoforms in question, with particular focus on dif-
ferential function of specific isoforms (the nature of
each splicing change and the precise exons
involved are shown in Supplementary Figure S1,
and referenced in Table 2). Dependent upon the
species in which previous work had been carried
out, one or more sequences were obtained from the
UCSC Genome Browser (Kent et al. 2002) along
with the NMR sequence. Once again, “in silico
splicing” and manual alignment was carried out
as described in the previous paragraph, however
in these cases the areas of alternative splicing were
selected as targets for assay design.
(b) Validation of exon junction sequences: Prior to
design of qPCR assays, sequence verification was
carried out by conventional RTPCR amplification
of the predicted fragments to confirm identity. In
all cases, primers were designed to the NMR se-
quence, with the aim of amplifying the target areas
as defined above and confirming amplicon identity
based on expected size. Where alternative spliced
isoforms were to be amplified (and where isoform
structure allowed) multiple primer sets were de-
signed to amplify each isoform individually. In the
cases of Aph1a, App andMapt, this was not possi-
ble therefore one set of primers was designed to
amplify all possible isoforms along with a set of
nested primers to isolate individual isoforms using
gel electrophoresis and band-stab PCR (Harries
et al. 2004). Primer sequences are given in Supple-
mentary Table S2. Template cDNA for the RTPCR
was created from a pool of mRNA from all NMR
age groups. This pool was reverse transcribed as
described above and used in PCR reactions using
either Microzone Megamix Royal (Clent Life Sci-
ence, Stourbridge, UK) or Platinum™ II Hot-Start
Green PCR Master Mix (ThermoFisher, Waltham,
MA, USA). Reaction conditions were set accord-
ing to manufacturer’s instructions except in some
cases where annealing temperatures and cycle
numbers used were specific to each amplicon.
These are given in Supplementary Table S2.
Amplicons were then checked using gel electro-
phoresis, and those which matched the expected
size were taken forward for the next steps. Of the
genes chosen, App and the p21b isoform of
Cdkn1a proved refractory to RTPCR amplification
and size-based verification. In the case of App, the
predicted sequence was used for the assay design.
For p21b, sequence homology between the known
(human/mouse) variants and the NMR genome
assembly was too low to design an assay with
any degree of confidence, so this isoform was
omitted at this stage.
(c) Sanger sequencing: Once amplicons had been ver-
ified by size, each was then sequenced to absolute-
ly confirm the in silico-predicted spliced mRNA
sequence. Sanger sequencing was carried out on
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the ABI 3730 platform using standard protocols.
PCR primers were designed to incorporate M13
forward and reverse tag sequences to enable use of
a common sequencing primer for all reactions (see
Supplementary Table S2). Sequence verification
was successful in all cases, however the NMR
Psen1 sequence showed no evidence of either the
3 base insertion (insTAC) or the 4 amino acid
(VRSQ) splice variants previously reported in hu-
man studies (De Jonghe et al. 1999; Janssen et al.
2000), while the NMR Psen2 sequence did not
contain the exon 5 skipped (PS2V) splice variant
seen in human and animal studies (Sato et al. 1999;
Moussavi Nik et al. 2015). Consequently, both
genes were omitted from further analysis.
(d) Assay design and verification: Following sequence
confirmation, TaqMan® assays were designed to
target regions as defined above. Forward primer,
reverse primer and reporter sequences of all assays
designed are given in Supplementary Table S3. To
determine assay efficiency and linearity, standard
curves were created from qPCR data generated
using a serial dilution of NMR cDNA (see “Re-
verse transcription” section above). Assay efficien-
cies and r2 values are given in Supplementary
Table S3.
Quantitative reverse transcriptase real-time PCR
A total of 1.0 μl cDNA (reverse transcribed as indicated
above) was added to a 5 μl qRTPCR reaction including
2.5 μl TaqMan® Universal Master Mix II, no UNG
(ThermoFisher, Waltham, MA, USA) and 0.25 μl cus-
tom TaqMan® probe and primer mix (corresponding to
900 nM each primer and 250 nM probe). Reactions
were run in triplicate on 384-well plates using the
QuantStudio 12 K Flex Real-Time PCR System
(ThermoFisher, Waltham, MA, USA). Amplification
conditions were a single cycle of 95 °C for 10 min
followed by 40 cycles of 95 °C for 15 s and 60 °C for
1 min. We first compared levels of splicing factor tran-
scripts in spleen and brain tissue from young NMR
(12 months) and young mice (3–4 months), followed
by assessment of splicing factor expression and alterna-
tive splicing patterns of key senescence or brain-related
genes in an extended series of NMR brain tissues from
foetal stages to extreme old age (21 to 22 years).
Data preparation
EDS files were uploaded to the ThermoFisher Cloud
(ThermoFisher, Waltham, MA, USA) and analysed
using the Relative Quantification qPCR App within
the software (ThermoFishera). To ensure we are looking
at real difference and not efficiency differences, assays
were designed to the same splice boundary and are as
conserved as possible. Relative threshold data were
calculated using the Crt method employed by the
ThermoFisher analytical software (ThermoFisherb)
along with correction for assay efficiencies
(Supplementary Table S3) to produce relative threshold
data and then imported into Excel (Microsoft, Red-
mond, WA, USA) and used for analysis using the
2−ΔΔCrt method. Separate analyses were carried out for
the splicing factor species comparison, splicing factor
brain series and the isoform/senescence brain series
datasets. First, Crt data from all transcripts measured,
housekeeping endogenous controls, calculated arithmet-
ic and geometric means of these controls along with
calculated “global” arithmetic and geometric means
across all genes measured for each dataset were then
uploaded to the RefFinder webtool (Xie et al. 2012) to
establish the most stable transcript(s). For both the spe-
cies comparison and the splicing factor brain series, the
geometric mean of the 4 housekeeping endogenous
controls (Idh3b, Ppia, Polr2a and Tbp) was most stable,
while in the isoform/senescence brain series the geomet-
ric mean across all genes measured was the most stable,
thus these were used for the respectiveΔCrt normalisa-
tion steps. For the ΔΔCrt normalisation, in the case of
the species comparison the arithmetic mean expression
value of all transcripts across all mouse samples from
both tissues was used as the comparator. In the splicing
factor brain series, the arithmetic mean expression level
in the 3–4 year old animals for each transcript was used
for ΔΔCrt normalisation, as this represents a mature
(i.e. non-developmental), but comparatively young time
point for comparison. For the alternatively spliced
isoform/senescence brain series, the arithmetic mean of
the expression levels in the 3–4-year-old animals for
each isoform was used (as above) for the statistical
analyses as this enabled us to test expression differences
between time points longitudinally for each isoform,
however for visualisation purposes (see Figs. 4 and 5)
and to allow for illustration of the relative expression
levels of each isoform, a separate analysis was carried
out using a median value across all isoforms for the
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ΔΔCrt normalisation. Following these ΔΔCrt normal-
isation steps, fold-changes were calculated using the
2−ΔΔCrt method. To ensure normal distribution and for
ease of visualisation, data were subsequently log trans-
formed; in the case of the species comparison, a log10
transformation was used due to the effect sizes, while for
the splicing factor brain series and isoform/senescence
brain series, a natural log was employed.
Statistical analysis
Differences in gene expression were tested using Stu-
dent’s t test for the species comparison dataset and linear
regressions for both the splicing factor brain series and
isoform/senescence brain series datasets. Student’s t test
were carried out in SPSS v15.0 (IBM, Armonk, NY,
USA) and linear regressions in STATA v15.1
(StataCorp, College Station, TX, USA). Benjamini,
Krieger and Yekutieli false discovery rate (FDR) calcu-
lations (Benjamini et al. 2006) were then performed to
account for multiple testing using GraphPad Prism 8.2.0
(GraphPad Software, San Diego, CA, USA), with the q
value set at 1%.
Results
Splicing factors are generally expressed at higher levels
in young NMR tissues compared to youngmouse tissues
We compared splicing factor expression in the spleen
and brain of young mice and naked mole-rats. We used
spleen and brain because of the known role of inflam-
mation in the ageing process and the known complexity
and prevalence in age-related diseases linked to brain
splicing patterns. Looking at splicing factor expression
as a whole, relative levels across all transcripts measured
are on average 1.6× and 2.1× higher in young NMR
brain and spleen respectively compared with young
mice. In spleen, all splicing factors tested demonstrated
altered expression in NMRs compared with mice. Most
genes were upregulated. In brain, although slightly few-
er splicing factors demonstrated altered expression com-
pared to mice, major differences in expression were
apparent, particularly for the Hnrnpa0, Hnrnph3,
Hnrnpk, Hnrnpul2, Srsf1, Srsf2, Srsf3 and Srsf6 genes
(p = < 0.001 for each). There was a striking similarity in
the overall pattern of species differences in splicing
factor expression in both tissues, with 13 out of the 16
splicing factors measured sharing directionality and ap-
proximate effect size across the two tissues (Fig. 1,
Supplementary Table S4).
Splicing factor transcript expression remains stable
during NMR ageing
To investigate changes in splicing factor expression
across the lifecourse, splicing factor expression was
measured from developmental stages (foetus, 1-day-
old or 2-week-old animals) until old age (21–22 years).
For all regulatory splicing factor transcripts measured,
significant expression changes were noted in the brain
tissue during at least one of the developmental phases
(foetus, 1-day-old or 2-week-old). Once the NMRs were
older than 2 weeks of age, for both splicing activators
and inhibitor transcripts, in most cases splicing factor
expression declined markedly (p < 0.001) and stabilised
at these low levels for more than two decades. This was
most marked for Hnrnpa1, Hnrnpa2b1, Hnrnph3 and
Hnrnpk splicing inhibitors (beta coefficients of expres-
sion change between foetal and 3/4 years were: 2.264,
0.997, 0.743 and 0.664 respectively; all p = <0.001) and
Srsf1, Srsf2, Srsf3, Srsf6 and Tra2b splicing activators
(beta coefficients: 1.050, 0.812, 1.541, 1.786 and 1.257
respectively; all p = <0.001; Figs. 2 and 3; Supplemen-
tary Table S5). However in the case of Hnrnpul2, levels
were lower in developmental states (up to 2 weeks of
age) and were higher in the older age cohorts (beta
coefficient: − 0.898; p = 0.001). During progression
from mature adults (3–4 years old) to old age (21 to
22 years), almost no alterations in splicing factor ex-
pression were noted. Only 3 of 16 regulatory splicing
factors (Hnrnph3, Hnrnpm and Srsf6) showed slight
alterations in splicing factor expression during ageing
in comparison to the 3–4-year-old animals (beta coeffi-
cients: − 0.181, − 0.245 and 0.529 respectively p =
0.036, 0.036 and 0.002; Figs. 2 and 3, Supplementary
Table S5). Similarly, the core spliceosome element
Sf3b1 did not show any alterations in brain expression
levels either during developmental phases or during
ageing, with the exception of a single nominally signif-
icant reduction in expression of Sf3b1 in the 13–15-
year-old group (beta coefficient: − 0.275; p = 0.006;
Supplementary table S6). This is contrary to previous
observations from our group in other species, where
dysregulation of splicing factor expression was noted
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in senescent astrocytes (Supplementary figure S2a; data
from Lye et al. 2019).
Cognition-related alternatively spliced isoform
transcripts remain stable during NMR ageing
To demonstrate the functional consequences of splicing
factor changes during NMR development and ageing,
we assessed changes in the isoform repertoire of a panel
of genes that we have previously demonstrated to be
differentially expressed in human astrocyte senescence;
some of which are also associatedwith cognitive decline
in human populations (Lye et al. 2019). Sanger sequenc-
ing of the relevant isoform-specific exon boundaries
demonstrated that the majority of the isoforms selected
for assessment were also present in NMR. This included
the p14Arf, p15 and p16INK-4a isoforms of the CDKN2A
gene; the mole-rat p16INK-4a transcript has poor se-
quence similarity to that of the mouse, and reportedly
presents with two early stop codons, predicting a trun-
cated protein and while the functional domains appear to
be partially preserved, the function of this cellular se-
nescence pathway may be already compromised (Kim
et al. 2011). The only cases where we did not find
evidence for a NMR isoform corresponding to the hu-
man and mouse isoforms was the p21b isoform of
Cdkn1a. Similar to the pattern seen in the splicing
factors, we identified few changes in the expression
levels of specific isoforms of cognition-related genes
in adult animals. Levels of Aph1a isoforms demonstrat-
ed elevated expression in the foetal period (beta coeffi-
cients: 0.411 and 1.423, both p = <0.001; Fig. 4; Sup-
plementary table S6) as did the expression of 2 of the 4
isoforms (App714 and App751) expressed from the App
gene (beta coefficients: 1.758, and 0.699; both p =
<0.001; Fig. 4; Supplementary table S6). Conversely
one App isoform, App695 demonstrated decreased ex-
pression in the foetal period (beta coefficient: − 0.809;
Fig. 1 Comparison of splicing
factor transcript expression levels
between mouse and naked mole-
rat (NMR) in brain and spleen.
The upper panel of each graph
shows log10 fold-change in ex-
pression levels, relative to the
mean expression across all tran-
scripts in both tissues in mice,
with open bars denoting expres-
sion in mouse and grey bars
showing expression in the NMR.
The lower panel of each graph
shows the difference between the
species. Significant differences
between species are denoted with
stars: * = p < 0.05, ** = p < 0.01,
*** = p < 0.001. All significant
differences noted on the graphs
met the FDR correction criteria at
p < 0.046.
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p = <0.001). Similarly, levels of both isoforms ofMapt,
both isoforms ofGfap and the M1 isoform of Aqp4 also
demonstrated decreased expression in the foetal period
(beta coefficients: − 1.096, − 4.661, − 2.393, − 1.563
and − 1.941; all p = <0.001; Fig. 4; Supplementary table
S6). In most cases, isoforms were regulated indepen-
dently of other isoforms of the same gene, indicating
that these represent splicing changes and not changes in
Fig. 2 Splicing inhibitor expression levels in naked mole-rat
(NMR) brain during development and ageing. Transcript expres-
sion levels of Hnrnp splicing inhibitors in NMR brain from foetus
through to 20–22 years old are shown. Data points represent β-
coefficients of log fold-change in expression levels for each tran-
script in each animal relative to the mean expression in the 3–
4 year old animals. The null point for each transcript is shown as a
light dotted line. Grey lines denote the mean values with error bars
at the 95% confidence intervals. Transcripts showing significant
differences from the 3–4 year old comparator group are denoted
with stars: * = p < 0.05, ** = p < 0.01, *** = p < 0.001. Associa-
tions which remain significant after FDR correction (p < 0.002) are
indicated in black, while those in grey represent nominal associa-
tions (p < 0.05).
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pre-mRNA transcription per se. Conversely, few chang-
es were noted after 3–4 years old, with isoform ratios
remaining consistent throughout the NMR ageing pro-
cess. (Fig. 4; Supplementary table S6). This is contrary
to observations from our group in other species, where
dysregulation of this isoform set was reported in senes-
cent astrocytes (supplementary figure S2b; data from
Lye et al. 2019).
Fig. 3 Splicing activator and core spliceosome component ex-
pression levels in naked mole-rat brain during development and
ageing. Transcript expression levels of Srsf splicing activators in
NMR brain from foetus through to 20–22 years old are shown.
Data points represent β-coefficients of log fold-change in expres-
sion levels for each transcript in each animal relative to the mean
expression in the 3–4-year-old animals. The null point for each
transcript is shown as a light dotted line. Grey lines denote the
mean values with error bars at the 95% confidence intervals.
Transcripts showing significant differences from the 3–4 year old
comparator group are denoted with stars: * = p < 0.05, ** =
p < 0.01, *** = p < 0.001. Associations which remain significant
after FDR correction (p < 0.002) are indicated in black, while those
in grey represent nominal associations (p < 0.05).
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Senescence-related transcripts remain stable
during NMR ageing
The negligible senescence noted in NMR (Buffenstein
2008; Stenvinkel and Shiels 2019) led us to evaluate the
expression of known markers of senescence across the
lifecourse in our samples. As seen for the splicing factor
genes, expression levels of Atm, Cdkn1a, and Tp53 genes
were elevated in the foetal state (beta coefficients: 0.883,
1.040 and 3.111; p = 0.002, < 0.001 and < 0.001 respec-
tively; Fig. 5; Supplementary table S7). Conversely, all 3
isoforms of the Cdkn2a/b locus (p14ARF, p16INK4a and
p15INK4b) demonstrated reduced expression in foetal ani-
mals compared with the mature animals (beta coefficients
− 2.414, − 3.472 and − 0.336; p = <0.001, < 0.001 and
0.024 respectively; Fig. 5; Supplementary table S7). Sub-
sequent trajectory for all the molecular markers of senes-
cence remained remarkably static from young adult to old
age (Fig. 5; Supplementary Table S7). This is in striking
contrast to our observations in replicatively senescent hu-
man astrocytes, where marked dysregulation of this iso-
form set was observed (Supplementary Figure S1b; data
from Lye et al. 2019).
Discussion
Here we present evidence that, contrary to observations
in both man and mouse, and more in keeping with their
negligible senescence phenotype (Buffenstein 2008),
adult NMRs maintain splicing regulatory capacity and
conservation of regulated alternative splicing with ad-
vancing age. Splicing factor expression is higher in
young adult NMRs than in young adult mice. We have
also identified that contrary to observations from our-
selves and others in humans (Harries et al. 2011; Holly
et al. 2013; Wang et al. 2018) and in human senescent
cells of several different lineages (Holly et al. 2013;
Latorre et al. 2017; Latorre et al. 2018b; Lye et al.
2019), splicing factor expression and patterns of isoform
expression in NMRs do not appear to alter with age.
Splicing factor expression has been demonstrated to
correlate with median strain lifespan in mice (Lee et al.
2016), and to have potential mechanistic roles in re-
sponse to dietary restriction in mice and invertebrates
(Heintz et al. 2016; Lee et al. 2019a) and may also
contribute to the superior stress resilience observed in
NMRs (Lewis et al. 2012).
Superior stress response is a well-established charac-
teristic of NMRs. NMRs have several enhanced stress
resistance mechanisms including enhanced mitochon-
drial antioxidant defences, enhanced proteostasis and
improved maintenance of genomic stability than do
other shorter lived rodents (Perez et al. 2009;
Petruseva et al. 2017; Munro et al. 2019). AS is another
fundamental cellular stress resilience mechanism. The
ability to adjust transcriptomic output has been associ-
ated with resistance to several endogenous and exoge-
nous cellular stressors in plants and animals
(Mastrangelo et al. 2012; Pai and Luca 2019). AS is
governed by the combinatorial control of a series of
splicing activators (SR proteins) and inhibitors
(hnRNPs) (Smith and Valcarcel 2000). These regulators
are dynamically expressed and responsive to multiple
cellular stressors (Biamonti and Caceres 2009;
Yamamoto et al. 2016; Kim Guisbert and Guisbert
2017; Jeffery et al. 2019). In humans and other species,
splicing factor expression has been demonstrated to
display altered expression in ageing and ageing pheno-
types (Harries et al. 2011; Lee et al. 2016; Lee et al.
2019b; Lye et al. 2019). Conceptually, one might expect
to see elevated expression of splicing enhancers and
decreased expression of splicing silencers in species
with conserved splicing regulation. However, each
splice event is regulated by the combinatorial binding
of a unique battery of splicing activators; inclusion of an
exon therefore may rely upon the activation of one
splice site, as well as the inhibition of a competitor site.
Fig. 4 Cognition-related alternatively spliced isoform transcript
expression levels in naked mole-rat brain during development and
ageing. Shown here are transcript expression levels of cognition-
related alternatively spliced isoform transcripts in NMR brain
during development and ageing from foetus through to 20–
22 years old. In order to show levels of individual isoform tran-
scripts, expression levels are plotted relative to the median expres-
sion value of all isoforms across all time points within each gene.
Data points represent β-coefficients of log fold-change in expres-
sion levels for each transcript in each animal relative to the mean
expression of each isoform in the 3–4 year old animals (null point
for each isoform shown as a light dotted line). Grey lines denote
the mean values with error bars at the 95% confidence intervals.
Isoform identities are shown in the legend at the lower left of each
graph. Transcripts showing significant differences from the 3–
4 year old comparator group are denoted with stars: * = p < 0.05,
** = p < 0.01, *** = p < 0.001. Associations which remain signif-
icant after FDR correction (p < 0.002) are indicated in black, while
those in grey represent nominal associations (p < 0.05).
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For these reasons, we do not expect to see directionality
changes at the level of the whole transcriptome. The
data presented here suggest that not only do NMRs start
with elevated splicing factor expression compared to
similarly sized rodents, but their splicing regulatory
capacity is well-maintained in old age.
Of all the organs, the brain is known for its diverse
splicing patterns and requirement for correctly regulated
splicing (Karlsson and Linnarsson 2017). This contributes
to many aspects of brain function such as activity patterns
and behavioural state (Que et al. 2019), correct configura-
tion of neural circuits (Sudhof 2017) and neuronal differ-
entiation, function and plasticity (Furlanis and Scheiffele
2018). Accordingly, dysregulation of splicing patterns is
characteristic of many neurodegenerative and
neurodevelopmental diseases in humans such as
Alzheimer’s disease, Parkinson’s disease and Autism
(Brudek et al. 2016; Parikshak et al. 2016; Raj et al.
2018). The reduced tolerance for splicing dysregulation
in brain makes it an ideal organ to study the long term
trajectory of splicing factor regulation. Dysregulated splic-
ing factor and isoform expression is a feature of senescent
astrocytes (Lye et al. 2019), as well as senescent skin and
lung fibroblasts, endothelial cells and cardiomyocytes
(Holly et al. 2013; Latorre et al. 2017; Latorre et al.
2018b). In other tissues, dysregulated splicing factor
Fig. 5 Senescence-related alternatively spliced isoform transcript
expression levels in naked mole-rat brain during development and
ageing. Shown here are transcript expression levels of senescence-
related alternatively spliced isoform transcripts in NMR brain
during development and ageing from foetus through to 20–
22 years old. In order to show levels of individual isoform tran-
scripts, expression levels are plotted relative to the median expres-
sion value of all isoforms across all time points within each gene.
Data points represent β-coefficients of log fold-change in expres-
sion levels for each transcript in each animal relative to the mean
expression of each isoform in the 3–4-year-old animals (null point
for each isoform shown as a light dotted line). Grey lines denote
the mean values with error bars at the 95% confidence intervals.
Where applicable, isoform identities are shown in the legend at the
lower left of the graph. Transcripts showing significant differences
from the 3–4 year old comparator group are denoted with stars:
* = p < 0.05, ** = p < 0.01, *** = p < 0.001. Associations which
remain significant after FDR correction (p < 0.002) are indicated
in black, while those in grey represent nominal associations
(p < 0.05).
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expression has also been suggested to be a driver of
cellular senescence; targeted knockdown of the splicing
activator SRSF2 or the splicing inhibitorHNRNPD in early
passage human primary endothelial cells is sufficient to
induce senescence (Latorre et al. 2018c), and restoration of
splicing factor expression using small molecule or genetic
means in human primary skin and lung fibroblasts and
endothelial cells rescues multiple aspects of the senescent
cell phenotype (Latorre et al. 2017; Latorre et al. 2018a;
Latorre et al. 2018c). The accumulation of senescent cells,
whilst known to confer early life longevity benefits in
terms of guarding against malignancy, contributing to
wound repair and embryonic development (Attaallah
et al. 2019) is known to be linked to ageing phenotypes.
Targeted removal of such cells is able to bring about a
remarkable rejuvenation of multiple aspects of age-related
pathology in genetically modified animals (Baker et al.
2011; Baker et al. 2016; Baar et al. 2017; Baar et al. 2018;
Baker and Petersen 2018). Newly emerging markers of
senescence such as the chromatin remodelling component
HMGB2 are elevated in senescent endothelial cells and
demonstrably higher in the circulation of people on ad-
verse ageing trajectories (Lawrence et al. 2018). These
observations suggest that the accumulation of senescent
cells may be at least partly causal to age-related pheno-
types, and that new approaches such as Ramen
microspectroscopy that are able to detect their accumula-
tion in vivo (Liendl et al. 2019) may provide useful bio-
markers to assess the efficacy of senotherapeutic interven-
tions in the future.
The data presented here are consistent with a model
by which the extreme longevity and conserved
healthspan characteristic of NMRs may arise from con-
servation of alternative splicing regulation and mainte-
nance of patterns of AS. This maintained transcriptomic
plasticity could then ensure a more robust response to
internal and external environmental stressors and avoid-
ance of cellular senescence. These data add weight to
the hypothesis that splicing regulation is a key feature in
the avoidance of cellular senescence, and provide a
potential explanation for the extreme longevity seen in
NMRs. In the future, the genes and pathways responsi-
ble for maintenance of splicing regulation andmolecular
stress response may be promising future therapeutic
targets for healthspan and lifespan interventions.
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